D Orazio & Associates Inc. Takes Position in Synopsys, Inc. $SNPS

D Orazio & Associates Inc. bought a new position in Synopsys, Inc. (NASDAQ:SNPS) during the third quarter, according to the company in its most recent filing with the SEC. The firm bought 1,895 shares of the semiconductor company’s stock, valued at approximately $935,000.

Several other hedge funds have also added to or reduced their stakes in the business. Vanguard Group Inc. increased its holdings in shares of Synopsys by 20.7% in the third quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company’s stock worth $8,970,415,000 after buying an additional 3,120,401 shares during the period. State Street Corp grew its position in Synopsys by 1.2% during the 2nd quarter. State Street Corp now owns 7,266,446 shares of the semiconductor company’s stock worth $3,725,362,000 after acquiring an additional 85,662 shares during the last quarter. Geode Capital Management LLC grew its position in Synopsys by 1.5% during the 2nd quarter. Geode Capital Management LLC now owns 3,545,892 shares of the semiconductor company’s stock worth $1,810,214,000 after acquiring an additional 51,043 shares during the last quarter. Ameriprise Financial Inc. increased its stake in Synopsys by 29.1% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock worth $1,333,095,000 after purchasing an additional 585,494 shares during the period. Finally, Alliancebernstein L.P. lifted its position in Synopsys by 10.9% in the second quarter. Alliancebernstein L.P. now owns 1,913,001 shares of the semiconductor company’s stock valued at $980,757,000 after purchasing an additional 187,790 shares during the last quarter. 85.47% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, insider Janet Lee sold 250 shares of the firm’s stock in a transaction on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the transaction, the insider directly owned 11,959 shares in the company, valued at $6,338,270. This trade represents a 2.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the sale, the chief financial officer directly owned 17,842 shares in the company, valued at $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 4,157 shares of company stock worth $1,945,036. Insiders own 0.62% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently issued reports on the stock. Bank of America upgraded shares of Synopsys from an “underperform” rating to a “neutral” rating and cut their target price for the stock from $525.00 to $500.00 in a report on Monday, December 8th. JPMorgan Chase & Co. raised their price target on shares of Synopsys from $600.00 to $650.00 and gave the stock an “overweight” rating in a report on Thursday, December 11th. Zacks Research upgraded shares of Synopsys from a “strong sell” rating to a “hold” rating in a research report on Monday, November 10th. Rosenblatt Securities upgraded shares of Synopsys from a “neutral” rating to a “buy” rating and dropped their target price for the stock from $605.00 to $560.00 in a report on Tuesday, December 9th. Finally, Morgan Stanley raised their target price on Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a research note on Friday, December 12th. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Synopsys presently has a consensus rating of “Moderate Buy” and a consensus price target of $553.57.

Synopsys Trading Up 0.0%

SNPS opened at $442.44 on Friday. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73. The stock has a market cap of $84.65 billion, a PE ratio of 55.37, a PEG ratio of 3.68 and a beta of 1.12. The business has a 50 day moving average of $474.32 and a 200-day moving average of $485.28.

Synopsys (NASDAQ:SNPS) last announced its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, beating analysts’ consensus estimates of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The firm had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.25 billion. During the same quarter in the previous year, the business posted $3.40 EPS. The company’s quarterly revenue was up 37.8% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Equities research analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.